Apple to Sign 4-To-5-Year DRAM Deal With Samsung

Apple is reportedly close to a four- to five-year long-term deal with Samsung supplying DRAM for the iPhone until 2031 or 2032, a concession MacRumors says the worsening chip shortage and supplier-favorable terms make unusual for Cupertino — and wallets will likely feel it in 2027.

Samsung’s side of the deal has a rather specific — and rather Apple-unfriendly — architecture: MacRumors reports Apple will commit to a fixed minimum volume of DRAM, but the Price per gigabyte floats. There will be a minimum order quantity in the LTA, but the pricing will alter depending on market conditions. That’s not how Apple usually buys memory, or anything else. Which is exactly why this matters.

The pricing clause is the story

Apple has historically been the memory industry’s toughest customer: short contracts, brutal price squeezing, multiple suppliers, no long-term exposure. That posture is now dead, at least for DRAM. Samsung's deal with Apple — and, separately, a similar LTA Apple has signed with SK hynix — flips the negotiating power.

Apple commits; Samsung gets a guaranteed revenue floor for years, plus a hedge if AI demand should cool. The Korean claim, via Maeil Business Newspaper, uses the word “unconventional” because for Apple it may have been rare, even though other Big Tech firms have reportedly already signed similar deals. For everyone else in Big Tech, it is already the standard operating model.

An unnamed semiconductor official told Maeil Business Newspaper that, considering Apple’s existing characteristics, this LTA with Samsung is an unconventional contract that has been rare in the past.

Why the DRAM market broke

Blame hyperscale AI. Every new {HBM-attached, DDR5-saturated} data center hall built for Llama-3-class training runs is a storage-grade memory sink, and DRAM prices have climbed accordingly.

Apple had originally ridden out the shortage on legacy inventory, but by February 2026 it was paying roughly double the previous rate for DRAM — a figure first reported by AppleInsider — for at least part of 2026. By July 2026, Apple had passed on the increases to consumers, raising most device prices, with further hikes on the refreshed models launched in September and October.

Hard downlink, hard uplink — DRAM in every iPhone 17-class device is now both a supply-chain variable and a bill-of-materials variable. Samsung’s LTA caps the first risk but not the second, since pricing floats. That is a rational trade only in a market you expect to stay tight.

Apple plans more price hikes

AppleInsider’s reporting says outright that further device price increases in 2027 are “very likely.” The company has already absorbed two rounds of increases this year — most devices in July, then the refreshed September/October launches — so a third-round pass-through in a new calendar year is not a bold prediction, it’s the continuation of an existing line item.

On Apple’s secondhand market, the same shortage is already visible: today’s trade-in update cut the max value of the iPhone 17 Pro by $45 (to $740) and the Pro Max by $30 (to $855), while raising older iPhones and adding six Samsung foldables — MacRumors details the full shift.

  • The deal runs to 2031–2032, starting from H1 2027 per MacRumors, with volume floors and floating prices.
  • SK hynix holds a parallel Apple LTA, reportedly on supplier-favorable terms — AppleInsider first reported that negotiation, and the reporting since confirms both are in play.
  • Minimum volumes, no fixed pricing — Apple takes volume risk; Samsung takes (upward) price risk only in the other direction.

A word of caution on sourcing: the deal has not been confirmed by either Apple or Samsung, and both DRAM pricing terms and the end date come from a single Korean trade publication’s sourcing.

But the direction of travel — Apple signing multi-year memory LTAs as the AI buildout eats the supply of conventional DRAM, HBM, and increasingly even the NAND fab space — is corroborated across AppleInsider, MacRumors, MacNews, and the Korean original. The next check point is whoever announces the deal’s formal signing, most plausibly alongside Samsung’s next earnings call or Apple’s Q1 FY2027 guidance.

Photo of author

Technology Desk

Technology Desk at Archyde.

FDA Grants Accelerated Approval to Neladalkib for ALK+ NSCLC After Alectinib or Multiple Therapies plus Chemo